| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Executive VP Finance, CFO
1 company
Rosenblum Mark J serves as a Chief Financial Officer at DCOY. Across recent SEC filings that breaks down to 6 buys and 0 sells.
Historically, Rosenblum Mark J's trades have earned a below-average insider score of 24/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -73.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | DCOY Salarius Pharmaceuticals, Inc. | Executive VP Finance, CFO | Buy | 20,000 | $0.80 | $16,000.00 | +11,299% | +1.3% | - | |
| May 31, 2022 | DCOY Salarius Pharmaceuticals, Inc. | Executive VP Finance, CFO | Buy | 28,000 | $0.18 | $5,040.00 | +23.3% | +19.4% | -68.7% | |
| Mar 3, 2022 | DCOY Salarius Pharmaceuticals, Inc. | Executive VP Finance, CFO | Buy | 76,246 | $0.39 | $29,812.19 | +223.8% | -54.7% | -77.8% | |
| Aug 17, 2020 | DCOY Salarius Pharmaceuticals, Inc. | Executive VP Finance, CFO | Buy | 5,000 | $1.00 | $5,000.00 | +71.4% | - | - | |
| Feb 19, 2020 | DCOY Salarius Pharmaceuticals, Inc. | Executive VP Finance, CFO | Buy | 2,000 | $0.95 | $1,900.00 | +40.0% | - | - | |
| Feb 13, 2020 | DCOY Salarius Pharmaceuticals, Inc. | Executive VP Finance, CFO | Buy | 5,000 | $0.86 | $4,295.00 | New | - | - |